AVIR Atea Pharmaceuticals, Inc. - common stock
$5,22
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$3–$6
66% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$9
+80% upside
P/E (TTM)
-2.7
ROE
-49.5%
Nettogewinnmarge
—
AVIR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.22
Marktkapitalisierung
$408M
P/E (TTM)
-2.7
EPS (TTM)
$-1.94
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-49.5%
Verschuldungsgrad
—
52W-Spanne
$3 – $6
AVIR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2020-12-31
→
2021-12-31
EPS
$-1.94
2019-12-31
→
2025-12-31
Freier Cashflow
—
2020-12-31
→
2022-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
AVIR
Peer-Median
P/E (TTM)
-2.7
44.2
P/B (K/B)
1.5
3.5
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
AVIR
Peer-Median
ROA
-40.6%
-39.4%
ROE
-49.5%
-64.1%
ROIC
-63.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
AVIR
Peer-Median
Current Ratio (Liquiditätsgrad)
7.8
6.5
Quick Ratio
2.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
AVIR
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
AVIR
Peer-Median
AVIR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 3 33,3%
- Kauf 4 44,4%
- Halten 2 22,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-15
Median
$10.00
Mittelwert
$9.42
← Unter allen Zielen
$5.22
Tief
$7.00
Hoch
$11.25
Median-Ziel
$10.00
+91,6%
Mittelwert-Ziel
$9.42
+80,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.41 | $-0.57 | 0.16% |
| 31. März 2026 | $-0.57 | $-0.60 | 0.03% |
| 31. Dezember 2025 | $-0.57 | $-0.54 | -0.03% |
| 30. September 2025 | $-0.53 | $-0.45 | -0.08% |
| 30. Juni 2025 | $-0.44 | $-0.42 | -0.02% |
| 31. März 2025 | $-0.40 | $-0.42 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $351M | $49M | |
| R&D Expense | $148M | $144M | $114M | $82M | $167M | $38M | |
| SG&A Expense | $33M | $49M | $50M | $49M | $46M | $22M | |
| Operating Expenses | $181M | $193M | $164M | $131M | $213M | $60M | |
| Operating Income | $-181M | $-193M | $-164M | $-131M | $138M | $-11M | |
| Pretax Income | $-165M | $-167M | $-135M | $-119M | $139M | $-11M | |
| Income Tax | $-6M | $925.0K | $1M | $-4M | $17M | · | |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| EPS (Basic) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 | $-0.51 | |
| EPS (Diluted) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 | |
| Shares (Basic) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 82,820,037 | 21,592,441 | |
| Shares (Diluted) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 88,249,243 | 21,592,441 | |
| EBITDA | $-181M | $-193M | $-164M | $-131M | $138M | $-11M |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $65M | $144M | $188M | $764M | $850M | |
| Prepaid Expense | $9M | $8M | $12M | $14M | $8M | $8M | |
| Current Assets | $311M | $462M | $590M | $661M | $772M | $863M | |
| PP&E (Net) | $457.0K | $873.0K | $1M | $2M | $23.0K | $48.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $184.0K | $180.0K | |
| Accum. Depreciation | $2M | $1M | $689.0K | $273.0K | $161.0K | $132.0K | |
| Other Non-current Assets | $3M | $197.0K | $1M | $1M | $466.0K | $107.0K | |
| Total Assets | $315M | $465M | $595M | $667M | $773M | $864M | |
| Accounts Payable | $13M | $4M | $4M | $3M | $5M | $60.0K | |
| Current Liabilities | $40M | $19M | $32M | $18M | $57M | $316M | |
| Capital Leases | $0 | $842.0K | $2M | $2M | · | · | |
| Other Non-current Liabilities | · | · | · | · | $6M | $36.0K | |
| Total Liabilities | $40M | $26M | $40M | $26M | $63M | $316M | |
| Common Stock | $78.0K | $84.0K | $83.0K | $83.0K | $83.0K | $82.0K | |
| Paid-in Capital | $798M | $803M | $751M | $701M | $654M | $613M | |
| Retained Earnings | $-523M | $-364M | $-196M | $-60M | $56M | $-65M | |
| AOCI | $174.0K | $233.0K | $207.0K | $-684.0K | · | · | |
| Stockholders' Equity | $275M | $439M | $555M | $641M | $710M | $548M | |
| Liabilities + Equity | $315M | $465M | $595M | $667M | $773M | $864M | |
| Shares Outstanding | 78,126,796 | 84,463,059 | 83,435,513 | 83,287,639 | 83,102,730 | 82,436,937 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $416.0K | $416.0K | $260.0K | $29.0K | $19.0K | |
| Stock-based Comp | $21M | $52M | $49M | $47M | $40M | $7M | |
| Deferred Tax | $-6M | $0 | · | · | · | $0 | |
| Operating Cash Flow | $-132M | $-135M | $-85M | $-121M | $-87M | $297M | |
| CapEx | · | · | · | $2M | $4.0K | $26.0K | |
| Investing Cash Flow | $189M | $56M | $40M | $-455M | $-4.0K | $-26.0K | |
| Stock Issued | · | · | · | · | $1M | $27.0K | |
| Stock Repurchased | $26M | $0 | · | · | · | · | |
| Net Stock Activity | $-26M | · | · | · | $1M | $27.0K | |
| Financing Cash Flow | $-26M | $267.0K | $257.0K | $370.0K | $1M | $532M | |
| Net Change in Cash | $31M | $-79M | $-45M | $-576M | $-86M | $828M | |
| Free Cash Flow | · | · | · | $-123M | $-87M | $297M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 39.4% | -22.7% | |
| Net Margin | · | · | · | · | 34.5% | -22.5% | |
| Pretax Margin | · | · | · | · | 39.4% | · | |
| EBITDA Margin | · | · | · | · | 39.4% | -22.7% | |
| ROA | -40.6% | -31.8% | -21.6% | -16.1% | 14.8% | -2.5% | |
| ROE | -49.5% | -37.5% | -23.9% | -17.8% | 18.8% | -4.7% | |
| ROIC | -63.2% | -44.2% | -29.8% | -19.8% | 17.0% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 | 2.7 | |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 | 2.7 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | 0.1 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 622.5% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $351M | $49M | |
| Net Income TTM | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| Market Cap | $279M | $283M | $254M | $401M | $743M | $3.44B | |
| P/E | -1.8 | -1.7 | -1.9 | -3.5 | 6.5 | -81.9 | |
| P/S | · | · | · | · | 2.1 | 70.8 | |
| P/B | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Tangible Book | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Cash Flow | -2.1 | -2.1 | -3.0 | -3.3 | -8.5 | 11.6 | |
| P / FCF | · | · | · | -3.3 | -8.5 | 11.6 | |
| Earnings Yield | -54.3% | -59.7% | -53.4% | -28.9% | 15.3% | -1.2% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $41M | $48M | $38M | $32M | $30M | $26M | $26M | $35M | $58M | $35M | $28M | $22M | $29M | $28M | $5M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $9M | $13M | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $11M | |
| Operating Expenses | $35M | $48M | $55M | $46M | $41M | $39M | $39M | $37M | $47M | $70M | $47M | $41M | $35M | $42M | $40M | $16M | |
| Operating Income | $-35M | $-48M | $-55M | $-46M | $-41M | $-39M | $-39M | $-37M | $-47M | $-70M | $-47M | $-41M | $-35M | $-42M | $-40M | $-16M | |
| Pretax Income | $-33M | $-45M | $-52M | $-42M | $-37M | $-34M | $-33M | $-31M | $-40M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-12M | |
| Income Tax | $24.0K | $50.0K | $-7M | $196.0K | $207.0K | $203.0K | $225.0K | $226.0K | $243.0K | $231.0K | $349.0K | $221.0K | $251.0K | $197.0K | $123.0K | $-4M | |
| Net Income | $-33M | $-45M | $-45M | $-42M | $-37M | $-34M | $-34M | $-31M | $-41M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-8M | |
| EPS (Basic) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| EPS (Diluted) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| Shares (Basic) | 80,050,518 | 79,198,204 | -166,463,391 | 79,052,154 | 83,747,335 | 85,159,254 | -168,327,178 | 84,422,000 | 84,253,700 | 83,916,193 | -166,741,793 | 83,399,769 | 83,399,377 | 83,332,397 | -166,447,151 | 83,258,537 | |
| Shares (Diluted) | 80,050,518 | 79,198,204 | -166,463,391 | 79,052,154 | 83,747,335 | 85,159,254 | -168,327,178 | 84,422,000 | 84,253,700 | 83,916,193 | -166,741,793 | 83,399,769 | 83,399,377 | 83,332,397 | -166,447,151 | 83,258,537 | |
| EBITDA | $-35M | $-48M | · | $-46M | $-41M | $-39M | · | $-37M | $-47M | $-70M | · | $-41M | $-35M | $-42M | · | $-16M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $79M | $96M | $77M | $88M | $119M | $65M | $98M | $243M | $161M | $144M | $138M | $214M | $183M | $188M | $176M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Prepaid Expense | $9M | $7M | $9M | $7M | $6M | $8M | $8M | $4M | $4M | $7M | $12M | $8M | $13M | $12M | $14M | $12M | |
| Current Assets | $229M | $263M | $311M | $336M | $386M | $434M | $462M | $487M | $506M | $549M | $590M | $603M | $621M | $632M | $661M | $682M | |
| PP&E (Net) | $249.0K | $353.0K | $457.0K | $561.0K | $665.0K | $769.0K | $873.0K | $977.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $1M | · | · | · | $689.0K | · | · | · | $273.0K | · | |
| Other Non-current Assets | $3M | $3M | $3M | $5M | $4M | $4M | $197.0K | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | · | |
| Total Assets | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Accounts Payable | $10M | $9M | $13M | $4M | $9M | $7M | $4M | $6M | $5M | $21M | $4M | $395.0K | $4M | $700.0K | $3M | $1M | |
| Current Liabilities | $28M | $33M | $40M | $20M | $20M | $22M | $19M | $25M | $27M | $41M | $32M | $19M | $16M | $12M | $18M | $16M | |
| Capital Leases | · | · | $0 | $213.0K | $425.0K | $634.0K | $842.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Total Liabilities | · | · | $40M | $27M | $27M | $29M | $26M | $32M | $34M | $49M | $40M | $26M | $24M | $20M | $26M | $23M | |
| Common Stock | $80.0K | $80.0K | $78.0K | $78.0K | $81.0K | $85.0K | $84.0K | $84.0K | $84.0K | $84.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | |
| Paid-in Capital | $805M | $802M | $798M | $793M | $800M | $809M | $803M | $788M | $776M | $763M | $751M | $739M | $726M | $714M | $701M | $689M | |
| Retained Earnings | $-601M | $-568M | $-523M | $-478M | $-436M | $-398M | $-364M | $-331M | $-300M | $-259M | $-196M | $-157M | $-124M | $-95M | $-60M | $-25M | |
| AOCI | $-96.0K | $-97.0K | $174.0K | $238.0K | $37.0K | $118.0K | $233.0K | $641.0K | $-280.0K | $-181.0K | $207.0K | $-262.0K | $-310.0K | $-307.0K | $-684.0K | $-855.0K | |
| Stockholders' Equity | $204M | $234M | $275M | $316M | $364M | $411M | $439M | $459M | $476M | $504M | $555M | $582M | $602M | $618M | $641M | $663M | |
| Liabilities + Equity | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Shares Outstanding | 80,204,699 | 80,027,099 | 78,126,796 | 78,126,796 | 81,137,478 | 85,579,475 | 84,463,059 | 84,463,059 | 84,422,000 | 84,223,100 | 83,435,513 | 83,435,513 | 83,399,377 | 83,399,377 | 83,287,639 | 83,287,639 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $106.0K | |
| Stock-based Comp | $3M | $4M | $5M | $5M | $5M | $7M | $14M | $12M | $13M | $13M | $12M | $12M | $12M | $13M | $12M | $12M | |
| Operating Cash Flow | $-37M | $-46M | $-28M | $-40M | $-33M | $-31M | $-30M | $-23M | $-42M | $-40M | $-22M | $-18M | $-16M | $-30M | $-22M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $20.0K | |
| Investing Cash Flow | $34M | $30M | $47M | $41M | $15M | $86M | $-3M | $-122M | $125M | $57M | $28M | $-59M | $47M | $24M | $33M | $-487M | |
| Stock Repurchased | · | · | $0 | $11M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $257.0K | $0 | $-11M | $-14M | $-347.0K | $0 | $117.0K | $0 | $150.0K | $0 | $92.0K | $0 | $165.0K | $0 | $147.0K | |
| Net Change in Cash | $-3M | $-16M | $18M | $-10M | $-32M | $55M | $-34M | $-145M | $82M | $17M | $6M | $-76M | $30M | $-5M | $12M | $-508M |
Rentabilität 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.6% | -12.8% | · | -10.1% | -8.2% | -6.9% | · | -5.7% | -7.1% | -10.6% | · | -5.1% | -4.3% | -5.2% | · | -1.1% | |
| ROE | -11.6% | -14.1% | · | -10.9% | -8.8% | -7.5% | · | -6.0% | -7.5% | -11.2% | · | -5.3% | -4.5% | -5.5% | · | -1.3% | |
| ROIC | -17.2% | -20.6% | · | -14.5% | -11.4% | -9.6% | · | -8.2% | -9.9% | -13.9% | · | -7.1% | -5.9% | -6.8% | · | -1.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 7.9 | · | 16.7 | 19.2 | 19.9 | · | 19.3 | 19.0 | 13.3 | · | 31.9 | 38.4 | 51.2 | · | 43.6 | |
| Quick Ratio | 2.7 | 2.4 | · | 3.8 | 4.4 | 5.5 | · | 3.9 | 9.1 | 3.9 | · | 7.3 | 13.2 | 14.8 | · | 11.6 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-158M | $-159M | · | $-145M | $-143M | $-169M | · | $-168M | $-165M | $-160M | · | $-105M | $-103M | $-117M | · | $-110M | |
| Market Cap | $373M | $431M | · | $227M | $292M | $256M | · | $283M | $279M | $340M | · | $250M | $312M | $279M | · | $474M | |
| P/E | -2.4 | -2.8 | · | -1.7 | -2.1 | -1.5 | · | -1.7 | -1.7 | -2.1 | · | -2.4 | -3.0 | -2.4 | · | -4.3 | |
| P/B | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Tangible Book | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Cash Flow | · | -9.3 | · | · | · | -8.4 | · | · | · | -8.5 | · | · | · | -9.4 | · | · | |
| Earnings Yield | -41.9% | -36.1% | · | -60.0% | -46.9% | -66.9% | · | -59.7% | -59.5% | -47.5% | · | -42.3% | -33.4% | -42.4% | · | -23.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | — | $351M |
| Betriebsgewinnmarge % | — | — | — | — | 39.4% |
| Nettoergebnis | $-158M | $-168M | $-136M | $-116M | $121M |
| Verwässerte EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | — | — | $-123M | $-87M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 133 Einreicher · $197.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 24 (-1 vs. Vorquartal) | 20 (+12 vs. Vorquartal) | 43 (+5 vs. Vorquartal) | 35 (-1 vs. Vorquartal) | +2.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BML Capital Management, LLC | $32.328.335 | 6.952.330 | 16,36% | Aktien |
| FMR LLC | $25.389.935 | 5.460.201 | 12,85% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $22.388.355 | 4.814.700 | 11,33% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.786.608 | 2.964.862 | 6,98% | Aktien |
| VANGUARD GROUP INC | $13.377.472 | 3.747.191 | 6,77% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $9.651.721 | 2.075.639 | 4,88% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $7.855.649 | 1.688.919 | 3,98% | Aktien |
| STATE STREET CORP | $7.683.655 | 1.652.399 | 3,89% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.006.141 | 1.506.697 | 3,55% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $5.598.935 | 1.204.072 | 2,83% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.260.080 | 1.131.200 | 2,66% | Aktien |
| Rosalind Advisors, Inc. | $4.978.058 | 1.070.550 | 2,52% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.783.129 | 1.059.700 | 1,91% | Aktien |
| BlackRock, Inc. | $3.726.687 | 801.438 | 1,89% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.930.360 | 630.185 | 1,48% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.839.323 | 610.607 | 1,44% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.184.575 | 469.801 | 1,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.077.322 | 446.736 | 1,05% | Aktien |
| CM Management, LLC | $1.650.750 | 355.000 | 0,84% | Aktien |
| BARCLAYS PLC | $1.615.519 | 347.423 | 0,82% | Aktien |
| BANQUE PICTET & CIE SA | $1.604.608 | 345.077 | 0,81% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.416.441 | 304.611 | 0,72% | Aktien |
| Quantinno Capital Management LP | $1.126.704 | 242.302 | 0,57% | Aktien |
| MORGAN STANLEY | $1.107.760 | 238.228 | 0,56% | Aktien |
| Opaleye Management Inc. | $1.092.750 | 235.000 | 0,55% | Aktien |
| HSBC HOLDINGS PLC | $1.023.272 | 221.009 | 0,52% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $979.020 | 210.542 | 0,50% | Aktien |
| Auour Investments LLC | $823.050 | 177.000 | 0,42% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $793.555 | 170.657 | 0,40% | Aktien |
| CITADEL ADVISORS LLC | $731.092 | 157.224 | 0,37% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $668.304 | 124.220 | 0,34% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $608.685 | 130.900 | 0,31% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $552.220 | 118.757 | 0,28% | Aktien |
| STRS OHIO | $547.305 | 117.700 | 0,28% | Aktien |
| RHUMBLINE ADVISERS | $423.720 | 91.124 | 0,21% | Aktien |
| Aldebaran Capital, LLC | $410.037 | 88.180 | 0,21% | Aktien |
| JPMORGAN CHASE & CO | $403.283 | 87.480 | 0,20% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $366.053 | 78.721 | 0,19% | Aktien |
| Bank of New York Mellon Corp | $364.895 | 78.472 | 0,18% | Aktien |
| D. E. Shaw & Co., Inc. | $347.629 | 74.759 | 0,18% | Aktien |
| DEUTSCHE BANK AG\ | $327.360 | 70.400 | 0,17% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $326.000 | 70.000 | 0,16% | Aktien |
| BANK OF AMERICA CORP /DE/ | $300.580 | 64.641 | 0,15% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $288.639 | 62.073 | 0,15% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $286.938 | 61.707 | 0,15% | Aktien |
| WELLS FARGO & COMPANY/MN | $276.164 | 59.390 | 0,14% | Aktien |
| Cubist Systematic Strategies, LLC | $254.545 | 87.774 | 0,13% | Aktien |
| Rangeley Capital, LLC | $202.275 | 43.500 | 0,10% | Aktien |
| MetLife Investment Management, LLC | $183.517 | 39.466 | 0,09% | Aktien |
| ALGERT GLOBAL LLC | $179.118 | 38.520 | 0,09% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $162.750 | 35.000 | 0,08% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $151.860 | 32.658 | 0,08% | Aktien |
| CITIGROUP INC | $141.923 | 30.521 | 0,07% | Aktien |
| RBF Capital, LLC | $139.500 | 30.000 | 0,07% | Aktien |
| Squarepoint Ops LLC | $136.319 | 29.316 | 0,07% | Aktien |
| Invesco Ltd. | $131.651 | 28.312 | 0,07% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $129.549 | 27.860 | 0,07% | Aktien |
| Vanguard Global Advisers, LLC | $119.417 | 25.681 | 0,06% | Aktien |
| JOHNSON INVESTMENT COUNSEL INC | $118.993 | 25.590 | 0,06% | Aktien |
| Certified Advisory Corp | $113.925 | 24.500 | 0,06% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $102.347 | 22.010 | 0,05% | Aktien |
| SEI INVESTMENTS CO | $88.527 | 19.038 | 0,04% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $82.296 | 17.698 | 0,04% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $78.762 | 16.938 | 0,04% | Aktien |
| Engineers Gate Manager LP | $78.148 | 16.806 | 0,04% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $77.446 | 16.655 | 0,04% | Aktien |
| Headlands Technologies LLC | $77.278 | 16.619 | 0,04% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $76.009 | 16.346 | 0,04% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $75.525 | 16.242 | 0,04% | Aktien |
| Spark Investment Management LLC | $75.330 | 16.200 | 0,04% | Aktien |
| Graham Capital Management, L.P. | $75.074 | 16.145 | 0,04% | Aktien |
| BAILARD, INC. | $74.865 | 16.100 | 0,04% | Aktien |
| RFG Advisory, LLC | $69.169 | 14.875 | 0,04% | Aktien |
| Trexquant Investment LP | $68.592 | 14.751 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $63.752 | 13.710 | 0,03% | Aktien |
| China Universal Asset Management Co., Ltd. | $59.222 | 12.736 | 0,03% | Aktien |
| PRUDENTIAL FINANCIAL INC | $56.637 | 12.180 | 0,03% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $55.749 | 11.989 | 0,03% | Aktien |
| Sunpointe, LLC | $55.535 | 11.943 | 0,03% | Aktien |
| ProShare Advisors LLC | $55.367 | 11.907 | 0,03% | Aktien |
| BLAIR WILLIAM & CO/IL | $52.661 | 11.325 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $52.080 | 11.200 | 0,03% | Kaufoption |
| NORTHERN TRUST CORP | $51.755 | 11.130 | 0,03% | Aktien |
| Cerity Partners LLC | $50.931 | 10.953 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $45.351 | 9.753 | 0,02% | Aktien |
| WOLVERINE TRADING, LLC | $43.747 | 14.982 | 0,02% | Aktien |
| UBS Group AG | $40.915 | 8.799 | 0,02% | Aktien |
| Blue Trust, Inc. | $40.455 | 8.700 | 0,02% | Aktien |
| Legal & General Group Plc | $32.931 | 7.082 | 0,02% | Aktien |
| Tower Research Capital LLC (TRC) | $28.844 | 6.203 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $27.500 | 5.914 | 0,01% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $20.691 | 3.846 | 0,01% | Aktien |
| Arax Advisory Partners | $19.642 | 4.224 | 0,01% | Aktien |
| Versant Capital Management, Inc | $19.623 | 4.220 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $16.642 | 3.579 | 0,01% | Aktien |
| Smartleaf Asset Management LLC | $15.332 | 3.325 | 0,01% | Aktien |
| SIMPLEX TRADING, LLC | $13.638 | 2.933 | 0,01% | Aktien |
| PNC Financial Services Group, Inc. | $12.950 | 2.785 | 0,01% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $12.476 | 2.319 | 0,01% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $10.443 | 3.601 | 0,01% | Aktien |
Unternehmensinsider 17 Insider · 6 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jean-Pierre Sommadossi | President, CEO, and Chairman | 3. Februar 2026 M | 767.830 | 0 | 0 | $0 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal and Secretary | 11. März 2026 M | 823.576 | 0 | 0 | $0 |
| Janet Mj Hammond | Chief Development Officer | 31. Januar 2026 A | 127.665 | 0 | 0 | $0 |
| John Vavricka | Chief Commercial Officer | 31. Januar 2026 A | 82.594 | 0 | 0 | $0 |
| Maria Arantxa Horga | Chief Medical Officer | 31. Januar 2026 A | 96.086 | 0 | 0 | $0 |
| Wayne Foster | EVP, Chief Accounting Officer | 31. Januar 2026 A | 79.329 | 0 | 0 | $0 |
| Berman Howard H. | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Jerome M. Adams | Direktor | 18. Juni 2026 A | 92.350 | 0 | 0 | $0 |
| Bruno Lucidi | Direktor | 18. Juni 2026 A | 142.350 | 0 | 0 | $0 |
| Polly A. Murphy | Direktor | 18. Juni 2026 A | 121.745 | 2 | 0 | $50.874 |
| Bruce Polsky | Direktor | 18. Juni 2026 A | 124.806 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Direktor | 18. Juni 2026 A | 92.350 | 0 | 0 | $0 |
| Arthur S Kirsch | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Franklin M Berger | Direktor | 18. Juni 2026 A | 536.097 | 0 | 0 | $0 |
| Andrew A. F. Hack | Direktor | 3. November 2020 C | 5.615.659 | 0 | 0 | $0 |
| Isaac Cheng | Direktor | 29. Oktober 2020 A | — | 0 | 0 | $0 |
| Chung K. Chu | — | 3. November 2020 C | 1.176.862 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Radoff Family Foundation, Radoff Bradley Louis, JEC II Associates, LLC, The MOS Trust, MOS PTC, LLC, Torok Michael, Berman Howard H., Nerium Partners LP, Nerium Capital LLC, Flynn James P. ×3 Einreichungen | 17. April 2025 | 4,00% | Änderung | Vorstandskampagne | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael | 16. Dezember 2024 | 8,50% | Erste Einreichung | — | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC ×2 Einreichungen | 28. November 2023 | — | Erste Einreichung | — | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×3 Einreichungen | 24. September 2021 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 82.125 NS | 31. Mai 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,23% | 127.806 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,08% | 241.243 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 4.309 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 151.732 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 472.207 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 662.851 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 61.782 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,02% | 2.889 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 30.344 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.798.217 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 263.930 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 408.133 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 54.465 SH | 8. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,01% | 32.303 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 3.294 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 345.893 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 2.575 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2.604 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 69.618 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 3.052 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8.300 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 65 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 181.682 SH | 8. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 16.361 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 58.155 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 18.537 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 47.410 NS | 31. Mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 11.053 NS | 31. Mai 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9.202 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 864.902 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.032.268 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.932 SH | 8. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 20 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 154.338 SH | 8. August 2026 | Täglich |